Literature DB >> 11413162

Iron overload diminishes atherosclerosis in apoE-deficient mice.

E A Kirk1, J W Heinecke, R C LeBoeuf.   

Abstract

It has been proposed that elevated levels of tissue iron increase the risk for atherosclerosis, perhaps by favoring the formation of pro-atherogenic oxidized LDL. Working with apoE-deficient (apoE(-/-)) mice, which do not require a high-fat diet to develop atherosclerosis, we compared the effects of standard diet (0.02% iron) or a 2% carbonyl iron diet. After 24 weeks, mice fed the 2% carbonyl iron diet had twice as much iron in their plasma, a ninefold increase in bleomycin-detectable free iron in their plasma, and ten times as much iron in their livers as control mice. Dietary iron overload caused a modest (30%) rise in plasma triglyceride and cholesterol. Nevertheless, this regimen did not exacerbate, but rather reduced the severity of atherosclerosis by 50%, and it failed to elevate hepatic levels of heme oxygenase mRNA, which is induced by many different oxidative insults in vitro. Moreover, hepatic levels of protein-bound dityrosine and ortho-tyrosine, two markers of metal-catalyzed oxidative damage in vitro, failed to rise in iron-overloaded animals. Our observations suggest that elevated serum and tissue levels of iron are not atherogenic in apoE(-/-) mice. Moreover, they call into question the hypothesis that elevated levels of tissue iron promote LDL oxidation and oxidative stress in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413162      PMCID: PMC200187          DOI: 10.1172/JCI7664

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Marked aortic hemosiderin deposits in a patient with hemochromatosis.

Authors:  A Jankus; N G Ardlie; R G Edwards; C J Schwartz
Journal:  Arch Pathol       Date:  1967-10

Review 2.  Regulating the fate of mRNA: the control of cellular iron metabolism.

Authors:  R D Klausner; T A Rouault; J B Harford
Journal:  Cell       Date:  1993-01-15       Impact factor: 41.582

3.  C282Y mutation in the HLA-H gene is not a risk factor for patients with myocardial infarction.

Authors:  J M Annichino-Bizzacchi; S T Saad; V R Arruda; J A Ramires; L H Siqueira; L C Chiaparini; A P Mansur
Journal:  J Cardiovasc Risk       Date:  2000-02

4.  Haemochromatosis gene mutations and risk of coronary artery disease.

Authors:  E Battiloro; D Ombres; E Pascale; E D'Ambrosio; R Verna; M Arca
Journal:  Eur J Hum Genet       Date:  2000-05       Impact factor: 4.246

5.  Iron and the sex difference in heart disease risk.

Authors:  J L Sullivan
Journal:  Lancet       Date:  1981-06-13       Impact factor: 79.321

6.  Gross aortic sudanophilia and hemosiderin deposition. A study on infants, children, and young adults.

Authors:  C J Schwartz; N G Ardie; R F Carter; J C Paterson
Journal:  Arch Pathol       Date:  1967-04

7.  Hemochromatosis, multiorgan hemosiderosis, and coronary artery disease.

Authors:  M Miller; G M Hutchins
Journal:  JAMA       Date:  1994-07-20       Impact factor: 56.272

8.  Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of 'free' iron in biological systems by using bleomycin-dependent degradation of DNA.

Authors:  J M Gutteridge; D A Rowley; B Halliwell
Journal:  Biochem J       Date:  1981-10-01       Impact factor: 3.857

9.  Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice.

Authors:  F Liao; A Andalibi; F C deBeer; A M Fogelman; A J Lusis
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  Formation of o-tyrosine and dityrosine in proteins during radiolytic and metal-catalyzed oxidation.

Authors:  T G Huggins; M C Wells-Knecht; N A Detorie; J W Baynes; S R Thorpe
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

View more
  18 in total

Review 1.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

2.  Hepcidin Deficiency Protects Against Atherosclerosis.

Authors:  Rajeev Malhotra; Florian Wunderer; Hanna J Barnes; Aranya Bagchi; Mary D Buswell; Caitlin D O'Rourke; Charles L Slocum; Clara D Ledsky; Kathryn M Peneyra; Haakon Sigurslid; Benjamin Corman; Kimberly B Johansson; David K Rhee; Kenneth D Bloch; Donald B Bloch
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-02       Impact factor: 8.311

3.  Ironing-Out the Role of Hepcidin in Atherosclerosis.

Authors:  Liang Guo; Atsushi Sakamoto; Anne Cornelissen; Charles C Hong; Aloke V Finn
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

4.  Testing the iron hypothesis in a mouse model of atherosclerosis.

Authors:  Léon Kautz; Victoria Gabayan; Xuping Wang; Judy Wu; James Onwuzurike; Grace Jung; Bo Qiao; Aldons J Lusis; Tomas Ganz; Elizabeta Nemeth
Journal:  Cell Rep       Date:  2013-12-05       Impact factor: 9.423

Review 5.  Pathological Roles of Iron in Cardiovascular Disease.

Authors:  Motoi Kobayashi; Tomohiro Suhara; Yuichi Baba; Nicholas K Kawasaki; Jason K Higa; Takashi Matsui
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

Review 6.  The role of hepcidin and iron homeostasis in atherosclerosis.

Authors:  Florian Wunderer; Lisa Traeger; Haakon H Sigurslid; Patrick Meybohm; Donald B Bloch; Rajeev Malhotra
Journal:  Pharmacol Res       Date:  2020-01-25       Impact factor: 7.658

7.  Chelation of mitochondrial iron prevents seizure-induced mitochondrial dysfunction and neuronal injury.

Authors:  Li-Ping Liang; Stuart G Jarrett; Manisha Patel
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

8.  The atherogenic effect of excess methionine intake.

Authors:  Aron M Troen; Esther Lutgens; Donald E Smith; Irwin H Rosenberg; Jacob Selhub
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

9.  Iron, oxidative stress, and clinical outcomes.

Authors:  Rajiv Agarwal
Journal:  Pediatr Nephrol       Date:  2007-11-21       Impact factor: 3.714

10.  Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD.

Authors:  Ko-Lin Kuo; Szu-Chun Hung; Tzong-Shyuan Lee; Der-Cherng Tarng
Journal:  J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.